Earlier recurrence of esophageal varices, following therapy, in patients with primary biliary cirrhosis (PBC) compared with non-PBC patients

Journal of Gastroenterology

Volumn 39, Issue 11, 2004, Pages 1085-1089

  Takeshita, Eiji ^a   Matsui, Hidetaka ^a   Shibata, Naozumi ^a   Furukawa, Shinya ^a   Yokota, Tomoyuki ^a   Murakami, Hidehiro ^a   Ikeda, Yoshiou ^a   Hiasa, Yoichi ^a   Matsuura, Bunzo ^a   Michitaka, Kojiro ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal varices; Primary biliary cirrhosis; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CHEMICAL PARAMETERS; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HEMATOLOGICAL PARAMETERS; HEPATITIS B; HEPATITIS C; HUMAN; KAPLAN MEIER METHOD; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PORTAL HYPERTENSION; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTHROMBIN TIME; RECURRENCE RISK; RECURRENT DISEASE; SCORING SYSTEM; VEIN LIGATION;

CASE-CONTROL STUDIES; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIGATION; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PROTHROMBIN TIME; RECURRENCE; TIME FACTORS;

EID: 10244246728     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1447-1     Document Type: Article

References (24)

1. Nakanuma Y, Ohta G, Kobayashi K, Kato Y. Histological and histometric examination of the intrahepatic portal vein branches in primary biliary cirrhosis without regenerative nodules. Am J Gastroenterol 1982;77:405-13.
2. Sherlock S. Noncirrhotic extrahepatic and intrahepatic portal hypertension. Semin Liver Dis 1982;2:202-10.
3. Nakanuma Y, Ohta G. Nodular hyperplasia of the liver in primary biliary cirrhosis of early histological stages. Am J Gastroenterol 1987;82:8-10.
4. Goudie BM, Burt AD, Macfarlane GJ, Boyle P, Gillis CR, MacSween RNM, et al. Risk factors and prognosis in primary biliary cirrhosis. Am J Gastroenterol 1989;84:713-6.
5. Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol 1990;25:119-26.
6. Takeshita E, Kumagi T, Matsui H, Abe M, Furukawa S, Onji M, et al. Esophagogastric varices as a prognostic factor for the determination of clinical stage in patients with primary biliary cirrhosis. J Gastroenterol 2003;38:1060-5.
7. Lebrec D, Degott C, Benhamou JP. Portal hypertension and primary biliary cirrhosis. Digestion 1976;14:220-6.
8. Navasa M, Pares A, Brugurera M, Caballeria J, Jaume Bosch J, Rodes J. Portal hypertension in primary biliary cirrhosis. Relationship with histological features. J Hepatol 1987;5:292-8.
9. Plevris JN, Dhariwal A, Elton RA, Finlayson NDC, Bouchier IAD, Haypes PC. The platelet count as a predictor of variceal hemorrhage in primary biliary cirrhosis. Am J Gastroenterol 1995;90:959-61.
10. Van Stiegmann GV, Cambre T, Sun TH. A new endoscopic elastic band ligation device. Gastrointest Endosc 1986;32:230-3.
11. Ohta Y. Report of Research Subgroup of Autoimmune Hepatitis/Primary Biliary Cirrhosis. Gastroenterol Jpn 1993;28:128-33.
12. Idezuki Y. The general rules for recording endoscopic findings on esophagogastric varices (1991). Japanese Research Society for Portal Hypertension. World J Surg 1995;19:420-3.
13. Mahl TC, Groszmann RJ. Pathophysiology of portal hypertension and variceal bleeding. Surg Clin North Am 1990;79:251-6.
14. Grund KE, Storek D, Farin G. Endoscopic argon plasma coagulation (APC). First clinical experiences in flexible endoscopy. Endosc Surg Allied Technol 1994;2:42-6.
15. Farin G, Grund KE. Technology of argon plasma coagulation with particular regard to endoscopic applications. Endosc Surg Allied Technol 1994;2:71-7.
16. Nakamura S, Mitsunaga A, Murata Y, Suzuki S, Hayashi N. Endoscopic induction of mucosal fibrosis by argon plasma coagulation (APC) for esophageal varices: A prospective randomized trial of ligation plus APC vs. ligation alone. Endoscopy 2001;22: 210-5.
17. Fleming CR, Ludwig J, Dickson ER. Asymptomatic primary biliary cirrhosis; presentation, histology and results with Dpenicillamine. Mayo Clin Proc 1978;53:587-93.
18. Okuda K, Nakashima T, Okudaira M, Kage M, Aida Y, Omata M, et al. Liver pathology of idiopathic portal hypertension. Comparison with noncirrhotic portal hypertension in India. Liver 1982;2:176-92.
19. Nakanuma Y, Nonomura A, Hayashi M, Doishita K, Takayanagi N, Uchida T, et al. Pathology of the liver in "idiopathic portal hypertension" associated with autoimmune disease. Acta Pathol Jpn 1989;39:586-92.
20. Cheng Y-S, Pan S, Lien G-S, Suk F-M, Wu M-S, Chen J-N, et al. Adjuvant sclerotherapy after ligation for the treatment of esophageal varices: A prospective, randomized long-term study. Gastrointest Endosc 2001;53:566-71.
21. Rosch J, Hanafee WN, Snow H. Transjuglar portal venography and radiologic portacaval shunt; an experimental study. Radiology 1969;92:1112-4.
22. Lebrec D, Nouel O, Corbi M, Benhamou JP. Propranolol - a medical treatment for portal hypertension? Lancet 1980;11:180-2.
23. Lebrec D, Poynard T, Hillon P, Benhamou JP. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A controlled study. N Engl J Med 1981;305:1371-4.
24. Ferguson JW, Tripathi D, Hayes PC. Review article: The management of acute variceal bleeding. Aliment Pharmacol Ther 2003; 18:253-62.